Purchase Order 75N91018P00446

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC valued at $6,021.00 on August 22, 2017 for service agreements supporting QIAxcel and QIACube instruments. Performance is at Bethesda, Maryland. The purchase order provides maintenance and support services to ensure continued availability of these sample preparation and analysis instruments. Performance concludes on September 20, 2018.</p>

<p>The National Institutes of Health Office of Acquisitions and Grants issued a purchase order to Qiagen, LLC for $4,566.00 on August 6, 2026 for QIAcube preventative maintenance. Performance occurs in Germantown, Maryland with completion due August 6, 2027. The order is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC valued at $3,684.00 on June 27, 2017, with an ultimate completion date of June 23, 2018. Performance occurs in Bethesda, Maryland. The order is priced on a firm fixed price basis with no set-aside designation applied.</p>

The National Cancer Institute awarded a $17,995 firm fixed price Blanket Purchase Agreement (BPA) call to Qiagen, LLC for a QIAcube Connect System-I with trade-in, with performance at the contractor's Germantown, Maryland facility. The award was issued without a set-aside designation on June 25, 2019, with an ultimate completion date of June 24, 2020. The QIAcube Connect System-I is an automated nucleic acid extraction instrument used in molecular diagnostic and research applications, supporting...

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for laboratory supplies valued at $4,368.70 on July 6, 2017, with an ultimate completion date of August 4, 2017. Work is performed in Germantown, Maryland. The order is for QIAGEN lab supplies on a firm fixed price basis with no set-aside used.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $23,000.00 on September 3, 2019, with an ultimate completion date of September 3, 2020. The order procures Product #830685QCII Large Panel Sub 1 under firm fixed price terms. Performance is at Qiagen's Germantown, Maryland location. No set-aside applies to this acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480 on June 9, 2020, with an ultimate completion date of June 14, 2021. Work is performed in Germantown, Maryland. The order is firm fixed price with no set-aside category. No additional source material specifies the scope of services or supplies procured under this purchase order.</p>

The National Cancer Institute awarded a purchase order to Qiagen, LLC for $4,995.00 on January 26, 2018, with completion scheduled for January 31, 2019. No set-aside was used. Performance takes place in Bethesda, Maryland. The order calls for firm fixed-price procurement of molecular diagnostics, scientific equipment, or bioinformatics solutions consistent with Qiagen's federal product portfolio of DNA and RNA extraction kits, next-generation sequencing supplies, sample preparation...

This firm-fixed-price purchase order for $24,995.00 was awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the QUICUBE CONNECT MDX THROUGH THE TRADE-IN &amp; TRADE-UP, with a completion date of December 26, 2024. Qiagen is an experienced federal contractor, providing a range of products and services to support the biomedical...

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $8,337.35 on April 16, 2018, with an ultimate completion date of May 12, 2018. Work is performed in Valencia, California. The order is priced as firm fixed price with no set-aside. The specific requirements are not detailed in the source.</p>